Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Chronic-Phase 34Leukemia 30Leukemia, Myeloid, Acute 18Leukemia, Lymphocytic, Chronic, B-Cell 13Blast Crisis 12Leukemia, Myeloid, Accelerated Phase 9Recurrence 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Burkitt Lymphoma 7Multiple Myeloma 6Philadelphia Chromosome 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Hematologic Neoplasms 5Lymphoma 4Hodgkin Disease 4Bronchiolitis Obliterans Syndrome 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Imatinib Mesylate 4venetoclax 1pevonedistat 1nilotinib 1Watchful Waiting 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Cytarabine 1Cladribine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypereosinophilic Syndrome × Dasatinib × Other hematologic neoplasm × Clear all
NCT00255346 2025-12-30

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

M.D. Anderson Cancer Center

Phase 2 Completed
68 enrolled 13 charts
MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡